The company is dedicating more funds to research, development and innovative projects.
A look at where tech developments are originating and what to expect.
Uncertainty caused by Britain’s EU departure creates opportunity for its neighbor.
Cultivating fresh thinking and continual adaptation is key.
The company will invest €13 million in the facility, which will make drug-coated balloons for peripheral artery disease.
With an established base of medtech companies and a strong workforce, Ireland remains a key player in the global supply chain.